T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Kilroy Realty
KRC
$4.24B
| $294M | 0.06% |
4,249,514
-432,850
| -9% | -$28.8M |
|
352
East-West Bancorp
EWBC
$18.5B
| $292M | 0.06% |
7,543,446
-230,387
| -3% | -$8.35M |
|
|
WBC
353
DELISTED
WABCO HOLDINGS INC.
WBC
| $290M | 0.06% |
2,764,146
+121,721
| +5% | +$12M |
|
|
ATHN
354
DELISTED
Athenahealth, Inc.
ATHN
| $288M | 0.06% |
1,977,848
-240,084
| -11% | -$30.1M |
|
355
Keurig Dr Pepper
KDP
$40.2B
| $286M | 0.06% |
3,996,467
-285,541
| -7% | -$19.8M |
|
356
Boston Properties
BXP
$10.9B
| $285M | 0.06% |
2,213,853
+9,690
| +0.4% | +$1.23M |
|
|
CMCSK
357
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
| $282M | 0.06% |
4,899,840
+655,881
| +15% | +$37.8M |
|
|
SIVB
358
DELISTED
SVB Financial Group
SIVB
| $282M | 0.06% |
2,425,366
-35,980
| -1% | -$3.92M |
|
|
CTLT
359
DELISTED
CATALENT, INC.
CTLT
| $281M | 0.06% |
10,064,184
+552,184
| +6% | +$14.5M |
|
360
Vodafone
VOD
$37.1B
| $281M | 0.06% |
8,211,460
+14,748
| +0.2% | +$497K |
|
361
Graco
GGG
$13.4B
| $278M | 0.06% |
10,399,506
+1,649,178
| +19% | +$42.4M |
|
362
Iron Mountain
IRM
$37.1B
| $276M | 0.06% |
7,145,194
+349,732
| +5% | +$12.7M |
|
363
Guidewire Software
GWRE
$14.4B
| $276M | 0.06% |
5,452,824
+94,009
| +2% | +$4.63M |
|
364
Cencora
COR
$60B
| $274M | 0.06% |
3,038,448
-1,021
| -0% | -$87.6K |
|
|
MBLY
365
DELISTED
Mobileye N.V.
MBLY
| $273M | 0.06% |
6,731,283
-293,447
| -4% | -$13.8M |
|
|
SNDK
366
DELISTED
SANDISK CORP
SNDK
| $272M | 0.06% |
2,775,935
+1,020,496
| +58% | +$97.6M |
|
367
Automatic Data Processing
ADP
$107B
| $271M | 0.06% |
3,253,006
-717,853
| -18% | -$58.2M |
|
|
XLNX
368
DELISTED
Xilinx Inc
XLNX
| $265M | 0.06% |
6,132,688
-31,046
| -0.5% | -$1.34M |
|
369
Diamondback Energy
FANG
$56.2B
| $264M | 0.06% |
4,418,208
+126,144
| +3% | +$8.02M |
|
|
P
370
DELISTED
Pandora Media Inc
P
| $262M | 0.06% |
14,721,009
-2,147,651
| -13% | -$42.5M |
|
371
Vail Resorts
MTN
$5.27B
| $260M | 0.06% |
2,853,870
-184,090
| -6% | -$16M |
|
372
Seagate
STX
$197B
| $258M | 0.05% |
3,884,034
-544,411
| -12% | -$33.8M |
|
373
Nordson
NDSN
$17.4B
| $257M | 0.05% |
3,300,373
-22,957
| -0.7% | -$1.74M |
|
374
Barclays
BCS
$94.6B
| $257M | 0.05% |
18,437,724
+1,050,432
| +6% | +$14.4M |
|
|
SE
375
DELISTED
Spectra Energy Corp Wi
SE
| $257M | 0.05% |
7,067,025
-3,654,886
| -34% | -$138M |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.